机器人供肾切除术在肥胖与非肥胖活体供肾者中的结局比较
单中心回顾性分析211例机器人供肾切除术供者,按BMI分为低BMI组(<30 kg/m²,137例)和高BMI组(≥30 kg/m²,74例),采用倾向评分重叠加权比较。加权后高BMI组手术时间延长15.6分钟(95%CI 6.4-24.8,P<0.001),但估计失血量、中转开放率、并发症、住院时间和6个月肾功能无差异。结论认为在严格选择的队列中,肥胖供者短期结局与非肥胖供者相当,仅手术时间轻度增加。
要点
- 肥胖活体供肾者行机器人供肾切除术,短期并发症和肾功能与非肥胖者相当。
- 肥胖供者手术时间加权后延长约15.6分钟,但失血量和住院时间无差异。
- 短期结局相当不等于长期供受者安全,扩大供体池需严格选择和长期随访。
核心结论
- 在严格选择的队列中,肥胖供者行机器人供肾切除术的短期围手术期和功能结局与非肥胖供者相当,仅手术时间轻度增加。
- 短期结局相当不能确立长期供者或受者的安全性,扩大供体池仍需严格选择、风险咨询和结构化长期监测。
研究设计与样本
- 单中心回顾性分析,纳入2020年8月至2025年4月连续212例机器人供肾切除术供者,排除1例协变量数据不完整者后,211例(低BMI<30 kg/m² 137例,高BMI≥30 kg/m² 74例)构成分析队列。
- 主要组间比较采用倾向评分重叠加权,加权差异和95%置信区间通过稳健加权回归估计。
主要发现
- 低BMI供者年龄略大(46.2岁 vs 42.2岁;最大失衡标准化均数差0.32),重叠加权后所有协变量差异降至近似零。
- 加权后高BMI组手术时间更长(加权差异+15.6分钟,95%CI 6.4-24.8;P<0.001)。
- 估计失血量、中转开放手术(1.4% vs 0.7%)、并发症(2.7% vs 2.2%;均为Clavien-Dindo I级)、住院时间和6个月肾功能无差异(加权P均>0.10)。
- 无围手术期死亡。
- 探索性亚组分析显示,高BMI供者中单肾动脉者(P=0.011)和左侧肾切除术者(P=0.024)手术时间更长,但失血量或并发症无差异。
临床怎么用
- 机器人供肾切除术可作为严格选择的肥胖活体供肾者的微创选择之一,但需告知手术时间可能延长。
- 肥胖供者纳入扩大供体池策略时,应结合 stringent 选择、风险咨询和结构化长期随访。
局限性
- 回顾性单中心设计可能引入选择偏倚和残余混杂。
- 随访仅至术后6个月,无法评估长期供者或受者安全性。
- 样本量有限,亚组分析为探索性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robotic donor nephrectomy (RDN) offers a minimally invasive alternative to open and laparoscopic techniques for living kidney donation. As obesity rises among potential donors, data comparing RDN outcomes between non-obese and obese donors remain limited. This study evaluates the safety and feasibility of RDN in obese living kidney donors. METHODS: A single-center retrospective analysis included 212 consecutive donors who underwent RDN between August 2020 and April 2025; after excluding one donor with incomplete covariate data, 211 (137 low BMI [< 30 kg/m2], 74 high BMI [≥ 30 kg/m2]) formed the analytic cohort. To account for baseline imbalance, the primary between-group comparison used propensity-score overlap weighting, with weighted differences and 95% confidence intervals (CIs) estimated by robust weighted regression. RESULTS: Low BMI donors were modestly older (46.2 vs. 42.2 years; largest imbalance, standardized mean difference 0.32); overlap weighting reduced all covariate differences to approximately zero. After weighting, operating time was longer in high BMI donors (weighted difference + 15.6 min, 95% CI 6.4-24.8; p < 0.001), whereas estimated blood loss, conversion to open surgery (1.4% vs. 0.7%), complications (2.7% vs. 2.2%; all Clavien-Dindo Grade I), length of stay, and renal function through six months did not differ (all weighted p > 0.10). No perioperative deaths occurred. Exploratory subgroup analyses showed longer operating times for high BMI donors with single renal arteries (p = 0.011) and left nephrectomies (p = 0.024), without differences in blood loss or complications. CONCLUSION: In a rigorously selected cohort, RDN yielded short-term perioperative and functional outcomes in obese donors comparable to non-obese donors, with only a modest increase in operative time that persisted after overlap weighting. These findings support RDN as one component of responsibly expanding the donor pool; however, short-term parity does not establish long-term donor or recipient safety, and expansion must remain contingent on stringent selection, risk counseling, and structured long-term surveillance.
引用
- Hallesy J, Nguyen D, Veeramgari DPR, et al. Expanding the living kidney donor pool: outcomes of robotic donor nephrectomy in obese versus non-obese donors. Surg Endosc. 2026. PMID: 42711589. doi:10.1007/s00464-026-13330-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。